Subscribe
12 July 2024NewsBig PharmaMarisa Woutersen

Novo Nordisk’s uphill battle in the counterfeit weight loss craze

As the popularity of weight-loss drugs like Ozempic soars, the Danish company has to manage seasoned criminals and international investigations to get results, finds Marisa Woutersen.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Eli Lilly takes further action over ‘dangerous’ diabetes drug fakes
25 June 2024   US drugmaker files six lawsuits over compounded tirzepatide products | At least five deaths associated with ‘generic’ Mounjaro, according to complaint | Fears over drug's 'unapproved' use for cosmetic weight loss.
Big Pharma
Ozempic counterfeits prompt Novo Nordisk to join forces with authorities
12 March 2024   Danish drugmaker testing suspect products and assisting with legal cases | High demand and global shortages have driven surge in weight-loss drug fakes.


Editor's picks

Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024

Editor's picks

Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024

More on this story

Americas
Eli Lilly takes further action over ‘dangerous’ diabetes drug fakes
25 June 2024   US drugmaker files six lawsuits over compounded tirzepatide products | At least five deaths associated with ‘generic’ Mounjaro, according to complaint | Fears over drug's 'unapproved' use for cosmetic weight loss.
Big Pharma
Ozempic counterfeits prompt Novo Nordisk to join forces with authorities
12 March 2024   Danish drugmaker testing suspect products and assisting with legal cases | High demand and global shortages have driven surge in weight-loss drug fakes.

More on this story

Americas
Eli Lilly takes further action over ‘dangerous’ diabetes drug fakes
25 June 2024   US drugmaker files six lawsuits over compounded tirzepatide products | At least five deaths associated with ‘generic’ Mounjaro, according to complaint | Fears over drug's 'unapproved' use for cosmetic weight loss.
Big Pharma
Ozempic counterfeits prompt Novo Nordisk to join forces with authorities
12 March 2024   Danish drugmaker testing suspect products and assisting with legal cases | High demand and global shortages have driven surge in weight-loss drug fakes.

More features

Regeneron targets almost 50 patents in suit against Sandoz
Litigation implications of the USPTO’s terminal disclaimer proposal
High-tech expert joins White & Case in US expansion plan
Ipsen files further suit against CSPC over pancreatic cancer drug generic
Court recommends $54m judgment in Abbott TM case
Federal Circuit denies rehearing in heart valve case
FTC endorses greater access to affordable biosimilars
‘Still on the outside’: UPC says Abbott PI not valid in Ireland